Overview of Dr. Grimm
Dr. Sean Grimm is a neurologist in Chicago, IL and is affiliated with Rush University Medical Center. He received his medical degree from The University of Texas Health Science Center at San Antonio and has been in practice 16 years. Dr. Grimm accepts several types of health insurance, listed below. He is one of 218 doctors at Rush University Medical Center who specialize in Neurology. He has more than 60 publications and over 500 citings.
Office
1725 W Harrison St
Ste 1010
Chicago, IL 60612Fax+1 312-942-1783
Education & Training
- New York Presbyterian Hospital (Cornell Campus)Residency, Neurology, 2001 - 2005
- The University of Texas Health Science Center at San AntonioClass of 2001
Certifications & Licensure
- IL State Medical License 2007 - 2026
- IN State Medical License 2024 - 2025
- MN State Medical License 2012 - 2013
- NY State Medical License 2002 - 2007
- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Clinical Trials
- Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer Start of enrollment: 2006 Dec 01
- Safety and Dose-Finding Study of TM-601 in Adults With Recurrent Malignant Glioma Start of enrollment: 2008 Feb 01
- A Study of 131I-TM601 in Adults With Recurrent Malignant Glioma Start of enrollment: 2008 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- A Phase II Trial of Bevacizumab in Patients with Recurrent/Progressive Solid Tumor Brain Metastases That Have Progressed Following Whole-Brain Radiation Therapy.Karan Dixit, Lauren Singer, Sean Aaron Grimm, Rimas V Lukas, Margaret A Schwartz
Cancers. 2024-06-04 - 30 citationsA phase I/II study of intrathecal trastuzumab in human epidermal growth factor receptor 2-positive (HER2-positive) cancer with leptomeningeal metastases: Safety, effic...Priya U Kumthekar, Michael J Avram, Andrew B Lassman, Nancy U Lin, Eudocia Lee
Neuro-Oncology. 2023-03-14 - 16 citationsA multi-institutional phase II trial of bevacizumab for recurrent and refractory meningioma.Priya Kumthekar, Sean Aaron Grimm, Roxanne T Aleman, Marc C Chamberlain, David Schiff
Neuro-Oncology Advances. 2022-08-19
Press Mentions
- 5 Facts You May Not Know About Brain TumorsNovember 15th, 2022
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
BCBS Illinois PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPOCoventry Health Care PPO Platinum
First Health PPO
Great West PPO
HealthLink PPO
Humana ChoiceCare Network PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: